|
0
|
|
Efficacy of cefiderocol and levofloxacin against Stenotrophomonas maltophilia in a hemorrhagic pneumonia mouse model.
(journals.asm.org)
|
Imoto W
…
Kakeya H
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#modeling
#infection
#amr
#pneumonia
|
|
0
|
|
Imipenem/cilastatin/relebactam dosing regimen justification using exposure-efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study.
(journals.asm.org)
|
Patel M
…
Gheyas F
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#amr
#pneumonia
|
|
0
|
|
Beyond plasma: defining the translation value of epithelial lining fluid exposure profiles for the treatment of pneumonia.
(academic.oup.com)
|
Fu Y
…
Nicolau DP
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#pneumonia
#pharmacodynamics
#antibiotic
|
|
0
|
|
Comparative effectiveness of two antimicrobial regimens for the treatment of pan-drug-resistant Acinetobacter baumannii infections: results from the DESPAIR study.
(journals.asm.org)
|
Pontikis K
…
Daikos GL
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#infection
#amr
#pneumonia
#treatment
#bacteremia
|
|
0
|
|
Infection point of care tests bridge the experience gap of antibiotic STOP decisions: clinicians versus students.
(academic.oup.com)
|
Singhal A
…
Singh S
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#infection
#pneumonia
#antimicrobial stewardship
#clinical decision-making
#point of care testing
|